🔗 Share this article

While America undertakes sweeping adjustments to its vaccination recommendations, an unexpected name has emerged unexpectedly: Høeg, a Danish American sports medicine doctor and public health researcher who rose to prominence by casting doubt on COVID-19 shots in the pandemic and has zeroed in on alleged deaths following Covid vaccination in her short time at the Food and Drug Administration.

Proposed Changes to Childhood Immunization Schedule

Public health authorities were set to unveil major revisions to the pediatric vaccine schedule earlier this month, bringing the US with Denmark’s national calendar, it is understood – a significant shift that would place the US out of step with many the world with insufficient data for public health gain. The planned update has been postponed until the new year.

In place of the top vaccines chief, Tracy Beth Høeg is listed to present at the event. She was newly appointed temporary leader of the FDA’s CDER, the fifth appointee to run the center this year.

Consolidating Power at the FDA

This interim role might represent a tighter collaboration between the pharmaceutical and biologics divisions as Høeg and Prasad strengthen their influence at the agency – and it signals a greater focus upon dismantling previously authorized vaccines at the FDA.

The new acting director has repeatedly called for halting some childhood immunization guidelines in the US to become more like the Danish model, a society with comprehensive healthcare and a number of inhabitants about the population of Wisconsin’s.

In her initial public appearances, she has continued to focus on vaccination policy – typically the responsibility of Dr. Prasad, chief of the FDA’s CBER – as opposed to pharmaceutical oversight.

Doubts Over Qualifications

Dr. Høeg has no apparent background in pharmaceutical research, oversight or leadership, which has been typical for former heads of the Center for Biologics Evaluation and Research. She has served at the FDA as a top consultant to the FDA chief and CBER since spring.

“She appears not to have the necessary background” for leading the pharmaceutical oversight division, said a neurologist and psychiatrist. “She has not conducted a randomized controlled trial. She has no expertise in leading a large organization. She lacks background in industry regulation.”

Former commissioners of the center would “be deeply familiar with legal statutes and the underlying principles of medication creation”, said Dr. Janet Woodcock. “Objectively, she has not acquired the type of experience that previous people who ran the center have had.”

The drug center has an vast portfolio at the FDA, the former commissioner emphasized.

“Many people just focuses on the novel medication approvals, but the generic program approves thousands of generic drugs. There’s a biosimilars division, non-prescription drug unit and other areas, and every single one must be supervised,” Dr. Woodcock noted. “The responsibility you don’t keep your eye on, that is precisely what that I always told people is going to come back to haunt you.”

There is also, a major leadership element to the job, which supervises in excess of 5,000 personnel. “It’s a huge leadership role, if you do it right,” Woodcock said.

Official Statement and Contentious Programs

In response to questions about Høeg’s qualifications and whether this assignment indicates greater collaboration among FDA leaders on vaccines, a spokesperson said that the “inquiries rely on flawed presumptions”.

“Her experience is consistent with the functions of her position,” the spokesperson stated, noting the months Høeg spent advising the FDA commissioner on “medication safety and approval science, including predictive safety algorithms and shot safety tracking”.

As the temporary head, Høeg inherits the commissioner’s controversial expedited review system, a controversial rapid drug-approval program that apparently worried her former heads. “By what process are these medications being selected for this fast-track system? Who makes the choices?” Dr. Howard questioned. “There is a lot of confidentiality going on at the agency right now.”

Broadly speaking, he said, “the Food and Drug Administration seems to be moving towards laxer rules of most medications, with the exception of shots.”

Documented Past Work on Immunizations

Concerning immunizations, Høeg has a clearer, if concerning, history, some experts observe. She authored a study using unconfirmed crowd-sourced reports to estimate the rate of myocarditis following Covid immunization. She advised the Florida chief medical officer Joseph Ladapo, who allegedly have modified findings to suggest Covid vaccinations are more dangerous than they are.

Included in her “wish list” for the incoming government encompassed altering guidelines for recently developed shots and halting “non-essential” immunizations, she stated post-election on a audio program. At the FDA, Dr. Høeg has according to sources suggested excluding adolescent males from obtaining Covid vaccinations.

“She is an all-around true believer who commences with her beliefs and tailors the evidence to fit the evidence in a very disingenuous, fraudulent fashion,” Howard stated.

Gaining Influence and a “Push for Payback”

Dr. Høeg became part of fellow contrarians, {like|